Efficacy and safety of transarterial chemoembolization plus sorafenib in patients with recurrent hepatocellular carcinoma after liver transplantation

Efficacy and safety of transarterial chemoembolization plus sorafenib in patients with recurrent hepatocellular carcinoma after liver transplantation

ObjectivesTo explore the benefit and safety of transarterial chemoembolization (TACE) in combination with sorafenib in patients with recurrent hepatocellular carcinoma (HCC) after orthotopic liver transplantation (OLT).MethodsIn this multi-center retrospective study, 106 patients with recurrent HCC...

Full description

Bibliographic Details
Main Authors: Xia Zhang, Lirong Cai, Jian Fang, Fengsui Chen, Fan Pan, Kun Zhang, Qian Huang, Yuju Huang, Dongliang Li, Lizhi Lv, Man Chen, Ruiying Yan, Yanhua Lai, Yonghai Peng, Zhixian Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Oncology
Subjects:
hepatocellular carcinoma
sorafenib
transarterial chemoembolization
liver transplantation
overall survival
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1101351/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.1101351/full

Similar Items